More specifically, we suggest a quantitative assessment of B cells, IgA, IgM and IgG in patients with a previous bacterial meningitis, at least 1 month after the onset of the disease or later, to avoid bias due to possible effects of the recent disease. The gene discussed is CD40LG; the disease is bacterial meningitis.